title: Contaminants in heparins continue to be unfolded.
authors.forename: J
authors.initials: J
authors.lastname: Fareed
authors.forename: M
authors.initials: M
authors.lastname: Ahluwalia
authors.forename: R
authors.initials: R
authors.lastname: Wahi
authors.forename: E
authors.initials: E
authors.lastname: Ramaccioti
authors.forename: D
authors.initials: D
authors.lastname: Hoppensteadt
authors.forename: R L
authors.initials: RL
authors.lastname: Bick
mesh_terms: D000707:Anaphylaxis / Q000097:blood / Q000139:chemically induced* / Q000276:immunology / Q000401:mortality; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects; D002809:Chondroitin Sulfates / Q000009:adverse effects* / Q000737:chemistry / Q000276:immunology / Q000302:isolation & purification; D004340:Drug Contamination; D056736:Drug Recalls; D019317:Evidence-Based Medicine; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007022:Hypotension / Q000097:blood / Q000139:chemically induced* / Q000276:immunology / Q000401:mortality; D018570:Risk Assessment
chemical_list: D000925:Anticoagulants; D006493:Heparin; D002809:Chondroitin Sulfates